| 1998 | | Augmented eradication rates of Helicobacter pylori by new combination therapy with lansoprazole, amoxicillin, and rebamipide. | 김영수, 김진홍, 이광재, 임현이, 조성원, 주희재, 함기백 |
| 2003 | | Chemoprevention of Helicobacter pylori-associated gastric carcinogenesis in a mouse model: is it possible? | 김명욱, 김영배, 김진홍, 유병무, 조성원, 한상욱, 함기백 |
| 2003 | | Effect of long-term administration of rebamipide on Helicobacter pylori infection in mice. | 김진홍, 유병무, 이기명, 조성원, 주희재, 함기백 |
| 1998 | | Helicobacter pylori infection, oxidative DNA damage, gastric carcinogenesis, and reversibility by rebamipide. | 김진홍, 이광재, 조성원, 함기백 |
| 2004 | | Preventive effect of the flavonoid, wogonin, against ethanol-induced gastric mucosal damage in rats. | 함기백 |
| 1998 | | Quantitative and qualitative usefulness of rebamipide in eradication regimen of Helicobacter pylori. | 김영수, 김진홍, 이광재, 임현이, 조성원, 주희재, 함기백 |
| 1997 | | Role of rebamipide on induction of heat-shock proteins and protection against reactive oxygen metabolite-mediated cell damage in cultured gastric mucosal cells. | 김영수, 김진홍, 윤정구, 조성원, 함기백 |
| 2023 | | Tenofovir disoproxil fumarate versus tenofovir alafenamide on risk of osteoporotic fracture in patients with chronic hepatitis B: A nationwide claims study in South Korea | 김순선 |
